Ceapro Inc

Company Profile

Ceapro Inc had its IPO on under the ticker symbol CRPOF.

The company operates in the Healthcare sector and Biotechnology industry. Ceapro Inc has a staff strength of 0 employees.

Stock update

Shares of Ceapro Inc opened at $0.31 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $0.31 - $0.31, and closed at $0.31.

This is a +4.75% increase from the previous day's closing price.

A total volume of 200 shares were traded at the close of the day’s session.

In the last one week, shares of Ceapro Inc have increased by +3%.

Ceapro Inc's Key Ratios

Ceapro Inc has a market cap of $27.32 million, indicating a price to book ratio of 1.7024 and a price to sales ratio of 1.8858.

In the last 12-months Ceapro Inc’s revenue was $18.84 million with a gross profit of $9.69 million and an EBITDA of $6.38 million. The EBITDA ratio measures Ceapro Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Ceapro Inc’s operating margin was 0% while its return on assets stood at 9.99% with a return of equity of 14.66%.

In Q1, Ceapro Inc’s quarterly earnings growth was a positive 0% while revenue growth was a negative 6.7%.

Ceapro Inc’s PE and PEG Ratio

Forward PE

0

Trailing PE

11.3333

PEG

Its diluted EPS in the last 12-months stands at $0.03 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Ceapro Inc’s profitability.

Ceapro Inc stock is trading at a EV to sales ratio of 1.5858 and a EV to EBITDA ratio of 3.5629. Its price to sales ratio in the trailing 12-months stood at 1.8858.

Ceapro Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$36.65 million

Total Liabilities

$1.47 million

Operating Cash Flow

$0

Capital Expenditure

$42062

Dividend Payout Ratio

0%

Ceapro Inc ended 2024 with $36.65 million in total assets and $0 in total liabilities. Its intangible assets were valued at $36.65 million while shareholder equity stood at $32.04 million.

Ceapro Inc ended 2024 with $0 in deferred long-term liabilities, $1.47 million in other current liabilities, in common stock, $10.50 million in retained earnings and $0 in goodwill. Its cash balance stood at $12.56 million and cash and short-term investments were $0. The company’s total short-term debt was $0 while long-term debt stood at $0.

Ceapro Inc’s total current assets stands at $19.96 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $2.91 million compared to accounts payable of $0 and inventory worth $4.25 million.

In 2024, Ceapro Inc's operating cash flow was $0 while its capital expenditure stood at $42062.

Comparatively, Ceapro Inc paid $0 in dividends in 2024.

Other key metrics

Current Trading Price

$0.31

52-Week High

$0.614

52-Week Low

$0.317

Analyst Target Price

$

Ceapro Inc stock is currently trading at $0.31 per share. It touched a 52-week high of $0.614 and a 52-week low of $0.614. Analysts tracking the stock have a 12-month average target price of $.

Its 50-day moving average was $0.33 and 200-day moving average was $0.43 The short ratio stood at 0 indicating a short percent outstanding of 0%.

Around 391.7% of the company’s stock are held by insiders while 0% are held by institutions.